tiprankstipranks
Trending News
More News >
Wanjia Group Holdings Ltd. (HK:0401)
:0401
Hong Kong Market
Advertisement

Wanjia Group Holdings Ltd. (0401) AI Stock Analysis

Compare
0 Followers

Top Page

HK:0401

Wanjia Group Holdings Ltd.

(0401)

Rating:53Neutral
Price Target:
HK$0.00
▼(-100.00% Downside)
The overall stock score of 53 reflects significant financial challenges and poor valuation metrics, which are partially offset by positive technical indicators. The company's declining revenues and persistent losses weigh heavily on its financial performance. However, the stock's positive momentum and technical strength provide some optimism for potential short-term gains.

Wanjia Group Holdings Ltd. (0401) vs. iShares MSCI Hong Kong ETF (EWH)

Wanjia Group Holdings Ltd. Business Overview & Revenue Model

Company DescriptionWanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the People's Republic of China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics in Fujian province. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.
How the Company Makes MoneyWanjia Group Holdings Ltd. generates revenue primarily through its real estate development and management activities, which include the sale and leasing of residential and commercial properties. Additionally, the company earns income from its investments in various sectors, such as commodities trading and technology ventures. Key revenue streams include rental income from properties, sales of developed real estate, and returns from its investment portfolio. The company may also benefit from strategic partnerships with other developers and businesses that enhance its market reach and operational efficiency, contributing to its overall earnings.

Wanjia Group Holdings Ltd. Financial Statement Overview

Summary
Wanjia Group Holdings Ltd. faces profitability challenges with consistent net losses and negative EBIT. While revenue growth is present, it is not sufficient to overcome the company's operating inefficiencies. The balance sheet is stable, with low leverage and a strong equity position, but the negative return on equity highlights ongoing operational issues. Cash flow generation remains a relative strength, providing some financial stability amidst profitability concerns.
Income Statement
40
Negative
The company has shown fluctuating revenue growth, with a 4.3% increase in the latest year. However, profitability is a concern with consistently negative EBIT and net income over recent years. The gross profit margin remains stable at around 30%, but net profit margins have been negative, indicating operational challenges.
Balance Sheet
55
Neutral
The balance sheet shows moderate strength with a debt-to-equity ratio of 0.21, suggesting manageable leverage. However, the return on equity is negative due to net losses, and the equity ratio is 62.7%, reflecting a reasonable proportion of equity financing. The company maintains a positive net debt position, which is favorable.
Cash Flow
60
Neutral
The company has positive operating cash flow, but free cash flow growth is modest. The operating cash flow to net income ratio is high, indicating effective cash generation from operations, despite net losses. The company's ability to convert earnings into cash flow is a positive indicator in an otherwise challenging financial situation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue171.41M161.69M181.09M173.70M154.82M114.09M
Gross Profit54.50M50.35M54.74M56.94M54.23M41.34M
EBITDA-3.83M4.13M-29.02M16.40M-34.64M8.16M
Net Income-35.67M-6.62M-39.98M1.82M-51.00M-4.54M
Balance Sheet
Total Assets121.19M106.82M117.10M173.45M191.82M223.59M
Cash, Cash Equivalents and Short-Term Investments32.06M24.08M18.23M9.88M5.77M25.10M
Total Debt25.58M11.72M15.60M25.17M20.99M22.12M
Total Liabilities42.47M38.19M41.91M53.22M63.72M52.51M
Stockholders Equity76.95M66.88M73.49M118.20M126.18M169.31M
Cash Flow
Free Cash Flow10.25M9.92M5.89M5.47M-4.86M-4.34M
Operating Cash Flow10.25M10.65M9.30M9.38M2.12M7.61M
Investing Cash Flow911.00K-697.00K674.00K-3.84M-6.93M-11.84M
Financing Cash Flow1.63M-3.71M-1.04M-802.00K-14.97M4.33M

Wanjia Group Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.10
Price Trends
50DMA
0.08
Positive
100DMA
0.08
Positive
200DMA
0.07
Positive
Market Momentum
MACD
<0.01
Negative
RSI
66.69
Neutral
STOCH
81.82
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0401, the sentiment is Positive. The current price of 0.1 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.08, and above the 200-day MA of 0.07, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 66.69 is Neutral, neither overbought nor oversold. The STOCH value of 81.82 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0401.

Wanjia Group Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
HK$10.57B30.146.77%1.95%29.81%10.40%
67
Neutral
HK$13.65B44.607.40%1.04%0.67%-1.75%
65
Neutral
HK$87.20M9.248.84%2.29%15.32%20.41%
54
Neutral
HK$314.65M-305.54%-35.02%-64.05%
53
Neutral
HK$54.34M-9.43%-10.71%83.45%
51
Neutral
$7.83B-0.18-40.10%2.29%21.46%-2.03%
HK$629.64M10.908.78%8.39%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0401
Wanjia Group Holdings Ltd.
0.10
0.05
100.00%
HK:0673
China Health Group
0.63
0.04
6.78%
HK:1931
IVD Medical Holding Limited
8.38
7.56
921.95%
HK:2192
Medlive Technology Co., Ltd.
14.07
6.27
80.38%
HK:2289
Charmacy Pharmaceutical Co., Ltd. Class H
5.83
-2.55
-30.43%
HK:8372
Grand Brilliance Group Holdings Limited
0.11
0.02
22.22%

Wanjia Group Holdings Ltd. Corporate Events

Wanjia Group Holdings Announces Registrar and Office Changes
Jan 7, 2025

Wanjia Group Holdings Limited has announced a change in its principal share registrar, transfer office, and registered office in the Cayman Islands, effective December 31, 2024. This strategic change is part of the company’s operational adjustments, as it continues to maintain its branch share registrar and transfer office in Hong Kong through Tricor Investor Services Limited.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 20, 2025